Ivantis Company
%20.jpg)
Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.
Investors
(INV)%20.jpg)
Headquarters:
Irvine, California, United States
Total Funding:
$132.4M
Founded Date:
2007-01-01
Employee Number:
101-250
Last Funding Type:
Series C
Investor Type:
For Profit
Investors Number:
16
Technology:
P4 Medicine
Funding Status:
Late Stage Venture
Estimated Revenue:
$10M to $50M
Industry:
Health Care, Health Diagnostics, Medical Device